Liao Zhijun, Wang Xinrui, Wang Xiaojiang, Li Lisheng, Lin Dexin
Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Fujian Medical University, Fuzhou, Fujian 350122, P.R. China.
Laboratory of Molecular Pathology, Fujian Provincial Cancer Hospital, Fuzhou, Fujian 350014, P.R. China.
Oncol Lett. 2017 Dec;14(6):7332-7338. doi: 10.3892/ol.2017.7128. Epub 2017 Oct 3.
DEP Domain Containing 7 (DEPDC7) is highly and specifically expressed in normal liver tissue, belonging to the class of genes of liver-selective cell communication. Although the function of DEPDC7 remains poorly understood, its expression is decreased in liver cancer compared with normal liver tissues. It has previously been demonstrated that knockdown of DEPDC7 promotes cell growth, S phase entry and cell mobility and invasion in HepG2 cells. In the present study, it was shown that DEPDC7 expression is downregulated in four hepatoma cell lines (SMMC-7721, Huh-7, SK-Hep-1 and HepG2) and 48 hepatoma tissues, determined using western blot and immunohistochemical analysis. When DEPDC7 is overexpressed in hepatoma cell lines (SK-Hep-1 and Huh-7), it inhibits cell proliferation and cell growth; inhibits cell cycle entry; and inhibits cell motility and invasion. These results, together with the results of knockdown experiments, demonstrate that DEPDC7 may have an important role in hepatoma cells growth and metastasis and suggest it could be a therapeutic target; however, studies are required to validate this hypothesis.
含DEP结构域蛋白7(DEPDC7)在正常肝组织中高表达且具有特异性,属于肝脏选择性细胞通讯相关基因类别。尽管对DEPDC7的功能仍了解甚少,但与正常肝组织相比,其在肝癌中的表达降低。此前已有研究表明,敲低DEPDC7可促进HepG2细胞的生长、进入S期以及细胞迁移和侵袭。在本研究中,通过蛋白质印迹法和免疫组织化学分析确定,在四种肝癌细胞系(SMMC-7721、Huh-7、SK-Hep-1和HepG2)以及48例肝癌组织中,DEPDC7表达下调。当在肝癌细胞系(SK-Hep-1和Huh-7)中过表达DEPDC7时,它可抑制细胞增殖和生长;抑制细胞周期进入;并抑制细胞运动和侵袭。这些结果与敲低实验结果共同表明,DEPDC7可能在肝癌细胞生长和转移中起重要作用,并提示其可能成为治疗靶点;然而,需要进一步研究来验证这一假说。